Now in its 13th year, ChinaTrials is the premier industry-focused clinical development event designed specifically for director-level and above executives with interest in China and North Asia development to gather to together solve the industry’s current challenges.
For more information contact Lychee.
R&D Company Rate $995 USD / 6,800 CNYIf your company has a drug or device in preclinical/clinical development, or a product already on the market, you are eligible for the R&D rate.R&D Company Group Rates* *If you are an R&D Company and your team is interested in sending multiple attendees, please email us at firstname.lastname@example.org to register as a group. The group discounts are listed below.Group Rate A (2 to 4 Attendees) 5,000 RMB / $750 USD per attendeeGroup Rate B (5 to 9 Attendees) 4,300 RMB / $585 USD per attendeeChina Emerging Company Rate $500 USD / 3,600 CNYIf your company is a new/small/developing domestic Chinese company with no offices outside of China, you may be eligible for a special discounted rate. Those eligible for this special rate include Founders, CEOs, CFOs, and other senior management of China-based healthcare operating companies in the products/services areas in the "new," "young" or "start-up" phase. This rate excludes consultants, advisers, established companies, etc. China Emerging Rate is subject to approval by Lychee Group. Please email Eric Lu at email@example.com to confirm your eligibility. If approved, you will then be sent the required code to enter that will enable you to register at this special rate.Government employees and those working at academic institutions are also eligible for this rate. Workshops are included with this rate.Standard Rate $1,695 USD / 11,500 CNYIf you are not eligible for the R&D Rate or the China Emerging Company Rate option listed below, you must select Standard Attendee when registering.
This page is secured with 256 bit encryption